Skip to main content
Fig. 4 | BMC Psychiatry

Fig. 4

From: A Sequential Multiple Assignment Randomized Trial (SMART) study of medication and CBT sequencing in the treatment of pediatric anxiety disorders

Fig. 4

Participant Timeline for Assessments The overall study duration will be 36 months. Trial duration, subsuming stages 1 and 2 each 12 weeks long, is 6 months (24 weeks). Recruitment will occur in months 1–24, and treatment will continue through month 30. Naturalistic follow-up will continue after the 24-week trial to assess the durability of study treatment effects and will range from 6 to 30 months, depending on when participants were recruited into the study. Months 36–43 be devoted to data analysis and draft publication of the manuscript, with submission for publication by month 50

Back to article page